Bluejay Diagnostics Inc (BJDX) saw an uptrend of 22.81% in the recent trading with $3.5 being its most recent. The current price level -71.89% lower than the highest price of $12.45 marked by the stock while trading over the past 52-weeks, whereas it is 177.78% higher than the lowest price of $1.26 the company dropped to over past 52-weeks. The latest news story on BJDX appeared in (GlobeNewswire) under the title “Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Hold by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.
Bluejay Diagnostics Inc Earnings – What Happened With BJDX
Coming around sales and income figures on BJDX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
BJDX – Bluejay Diagnostics Inc Stock Earnings Estimates
The perspective of Bluejay Diagnostics Inc (NASDAQ:BJDX)’s current quarter earnings identifies that analysts are in consensus over the estimate of -340 for stock’s EPS in the current quarter. Company’s EPS for the last quarter was -712.
Bluejay Diagnostics Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.49 million. BJDX does have institutional investors; and they hold 6.63% of the stock.
Key Metrics for BJDX
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Bluejay Diagnostics Inc has a debt to equity ratio of 0.03.
